东方生物(688298.SH)：公司及多个子公司取得炎症标志物检测试剂盒等几款医疗器械注册证书

Core Insights - The company, Dongfang Biological (688298.SH), announced the acquisition of several medical device registration certificates, including inflammation marker detection kits and COVID-19/FluA&B antigen combination test kits [1] Group 1: Product Development - The certification of the inflammation marker detection kit enhances the company's product lineup in the domestic inflammation indicator detection field [1] - The new products expand the application areas of the flow cytometry technology platform, benefiting the overall market expansion in China [1] Group 2: International Market Expansion - The company has obtained self-test certificates for respiratory detection, drug detection, and tumor marker detection products in key international markets such as the United States, the United Kingdom, and Thailand [1] - This expansion enriches the variety of products and testing applications in core international markets, facilitating growth in these regions [1]